Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd has announced that the European Commission (EC) has ...

A new company is responsible for Japanese promotional activities for Actair, Stallergenes Greer’s sublingual immunotherapy ...

British drugmaker AstraZeneca (LSE: AZN) has gained European approval for Imfinzi (durvalumab) in combination with ...

Multinational pharmaceutical companies (MNCs) are facing significant challenges in China's vaccine market, as regulatory ...

UK pharma major AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Anktiva (nogapendekin alfa inbakicept) for adults with BCG-unresponsive non-muscle invasive bladder cancer, where ...

In the high-stakes world of drug development, a pill is never just a pill. Every oral drug that reaches the market has passed through a tightly managed series of steps—none more critical, or more ...

A new European Commission strategy promises to lift life sciences in the region out of a two-decade slump by tackling ...

French biotech MaaT Pharma has signed a licensing and distribution agreement with UK-based Clinigen, positioning the company ...

UK-based contract research, development and manufacturing organization Ingenza has named Nick Challoner as its new chief ...

US-Japan venture capital firm AN Venture Partners has wrapped up its first fund at $200 million, marking one of the largest ...

The UK government today launched its 10 Year Health Plan for the National Health Service (NHS), promising a "new era." A new ...